NASDAQ · Analyst Forecast

10x Genomics, Inc. (TXG) Stock Forecast & Price Target

$56.30 NASDAQ: TXG Market Cap $6.84B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering 10x Genomics, Inc. (TXG), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For 10x Genomics, Inc., analysts forecast revenue rising from $636.44M in 2025 to $922.46M in 2030; the average estimate for 2030 earnings per share is $0.30; with published estimates ranging from $0.29 to $0.32; 12 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$56.30
Consensus targetThe average of the price targets analysts have published.$82.40
Median targetThe middle target, less affected by a single outlier.$75.00
Highest targetThe most optimistic published target.$110.00
Lowest targetThe most pessimistic published target.$61.00
Difference from priceHow far the consensus target sits from today’s price.+46.4%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$610.45M$636.44M$659.09M4
2026$627.34M$629.64M$632.12M11
2027$670.97M$703.27M$728.26M12
2028$706.75M$779.79M$828.18M11
2029$825.46M$860.61M$891.23M5
2030$884.80M$922.46M$955.29M5

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$0.51−$0.43−$0.284
2026−$0.70−$0.63−$0.5911
2027−$1.16−$0.67$0.0112
2028−$0.64−$0.37−$0.1811
2029−$0.10−$0.10−$0.095
2030$0.29$0.30$0.325

10x Genomics, Inc. (TXG) forecast — frequently asked questions

What is the analyst price target for 10x Genomics, Inc.?

Analysts covering 10x Genomics, Inc. (TXG) have a consensus price target of $82.40, 46.4% above the current price of $56.30. Published targets range from $61.00 to $110.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for 10x Genomics, Inc.'s earnings?

The average analyst estimate for 10x Genomics, Inc. (TXG) earnings per share in 2030 is 0.30, with individual estimates between 0.29 and 0.32.

How much revenue is 10x Genomics, Inc. expected to make?

Analysts forecast 10x Genomics, Inc. (TXG) revenue of $922.46M in 2030, based on 5 published estimates.

How many analysts cover TXG?

12 analysts contribute estimates for 10x Genomics, Inc. (TXG). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.